The company named Sadik Kassim, PhD, its chief technology officer, and hematological and gene engineering research specialist Tirtha Chakraborty, PhD, joined as vice president of research.
The appointments follow Vor’s recent move to a new headquarters in Cambridge, Mass., and the recent appointment of Dr. Robert Ang as the company’s new CEO and president.
More articles on biologics:
Dr. Raymond Gardocki: Endoscopic spine surgery in the US — will it catch up to other countries?
Clarifying patient, provider goals before surgery and robotics in spine: Q&A with Dr. Kris Radcliff
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
